Genes and Sjögren's Syndrome

Rheumatic Disease Clinics of North America

Volumn 34, Issue 4, 2008, Pages 847-868

  Cobb, Beth L ^a   Lessard, Christopher J ^a,b   Harley, John B ^a,b,c   Moser, Kathy L ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Association; Genetics; HLA; Sj gren's syndrome

Indexed keywords

APOLIPOPROTEIN E; AUTOANTIBODY; CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; IMMUNOGLOBULIN ALLOTYPE; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; MANNOSE BINDING LECTIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN TYROSINE PHOSPHATASE; RO52 AUTOANTIBODY; STAT4 PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNE THYROID DISEASE; DNA POLYMORPHISM; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; HLA SYSTEM; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; SJOGREN'S SYNDROME;

EID: 54549125740     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2008.08.003     Document Type: Review

References (149)

1. Bolstad A.I., and Jonsson R. Genetic aspects of Sjogren's syndrome. Arthritis Res 4 6 (2002) 353-359
2. Bowman S.J., Ibrahim G.H., Holmes G., et al. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 33 1 (2004) 39-43
3. Dafni U.G., Tzioufas A.G., Staikos P., et al. Prevalence of Sjogren's syndrome in a closed rural community. Ann Rheum Dis 56 9 (1997) 521-525
4. Haugen A.J., Peen E., Hulten B., et al. Estimation of the prevalence of primary Sjogren's syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol 37 1 (2008) 30-34
5. Manthorpe R., Frost-Larsen K., Isager H., et al. Sjogren's syndrome. A review with emphasis on immunological features. Allergy 36 3 (1981) 139-153
6. Sanchez-Guerrero J., Perez-Dosal M.R., Cardenas-Velazquez F., et al. Prevalence of Sjogren's syndrome in ambulatory patients according to the American-European Consensus Group criteria. Rheumatology (Oxford) 44 2 (2005) 235-240
7. Besana C., Salmaggi C., Pellegrino C., et al. Chronic bilateral dacryo-adenitis in identical twins: a possible incomplete form of Sjogren syndrome. Eur J Pediatr 150 9 (1991) 652-655
8. Bolstad A.I., Haga H.J., Wassmuth R., et al. Monozygotic twins with primary Sjogren's syndrome. J Rheumatol 27 9 (2000) 2264-2266
9. Houghton K.M., Cabral D.A., Petty R.E., et al. Primary Sjogren's syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia. J Rheumatol 32 8 (2005) 1603-1606
10. Scofield R.H., Kurien B.T., and Reichlin M. Immunologically restricted and inhibitory anti-Ro/SSA in monozygotic twins. Lupus 6 4 (1997) 395-398
11. Boling E.P., Wen J., Reveille J.D., et al. Primary Sjogren's syndrome and autoimmune hemolytic anemia in sisters. A family study. Am J Med 74 6 (1983) 1066-1071
12. Lichtenfeld J.L., Kirschner R.H., and Wiernik P.H. Familial Sjogren's syndrome with associated primary salivary gland lymphoma. Am J Med 60 2 (1976) 286-292
13. Mason A.M., and Golding P.L. Multiple immunological abnormalities in a family. J Clin Pathol 24 8 (1971) 732-735
14. Reveille J.D. The molecular genetics of systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 4 5 (1992) 644-656
15. Sabio J.M., Milla E., and Jimenez-Alonso J. A multicase family with primary Sjogren's syndrome. J Rheumatol 28 8 (2001) 1932-1934
16. Sestak A.L., Shaver T.S., Moser K.L., et al. Familial aggregation of lupus and autoimmunity in an unusual multiplex pedigree. J Rheumatol 26 7 (1999) 1495-1499
17. Reveille J.D., Wilson R.W., Provost T.T., et al. Primary Sjogren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med 101 6 (1984) 748-756
18. Criswell L.A., Pfeiffer K.A., Lum R.F., et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76 4 (2005) 561-571
19. Giles I., and Isenberg D. Fatigue in primary Sjogren's syndrome: is there a link with the fibromyalgia syndrome?. Ann Rheum Dis 59 11 (2000) 875-878
20. Fox R.P. Head and neck findings in systemic lupus erythematosus: Sjogren's syndrome and the eye, ear, and larynx (2008), Lippencott, Williams, Wilkins, Philadelphia
21. Baechler E.C., Batliwalla F.M., Reed A.M., et al. Gene expression profiling in human autoimmunity. Immunol Rev 210 (2006) 120-137
22. Graham R.R., Ortmann W.A., Langefeld C.D., et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 71 3 (2002) 543-553
23. Barreto M., Santos E., Ferreira R., et al. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 12 8 (2004) 620-626
24. Blomhoff A., Kemp E.H., Gawkrodger D.J., et al. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res 18 1 (2005) 55-58
25. Blomhoff A., Lie B.A., Myhre A.G., et al. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 89 7 (2004) 3474-3476
26. Furugaki K., Shirasawa S., Ishikawa N., et al. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet 49 3 (2004) 166-168
27. Hunt K.A., McGovern D.P., Kumar P.J., et al. A common CTLA4 haplotype associated with coeliac disease. Eur J Hum Genet 13 4 (2005) 440-444
28. Lee C.S., Lee Y.J., Liu H.F., et al. Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in Chinese. Clin Rheumatol 22 3 (2003) 221-224
29. Torres B., Aguilar F., Franco E., et al. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 50 7 (2004) 2211-2215
30. Zhou Y., Huang D., Paris P.L., et al. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis. Arthritis Rheum 50 8 (2004) 2645-2650
31. Prokunina L., and Alarcon-Riquelme M. The genetic basis of systemic lupus erythematosus-knowledge of today and thoughts for tomorrow. Hum Mol Genet 13 Spec No 1 (2004) R143-R148
32. Begovich A.B., Carlton V.E., Honigberg L.A., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75 2 (2004) 330-337
33. Bottini N., Musumeci L., Alonso A., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet 36 4 (2004) 337-338
34. Ladner M.B., Bottini N., Valdes A.M., et al. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 66 1 (2005) 60-64
35. Onengut-Gumuscu S., Ewens K.G., Spielman R.S., et al. A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type 1 diabetes in multiplex families. Genes Immun 5 8 (2004) 678-680
36. Orozco G., Sanchez E., Gonzalez-Gay M.A., et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 52 1 (2005) 219-224
37. Velaga M.R., Wilson V., Jennings C.E., et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89 11 (2004) 5862-5865
38. Korman B.D., Alba M.I., Le J.M., et al. Variant form of STAT4 is associated with primary Sjogren's syndrome. Genes Immun 9 3 (2008) 267-270
39. Marrack P., Kappler J., and Kotzin B.L. Autoimmune disease: why and where it occurs. Nat Med 7 8 (2001) 899-905
40. Easton D.F., Pooley K.A., Dunning A.M., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 7148 (2007) 1087-1093
41. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40 2 (2008) 204-210
42. Hom G., Graham R.R., Modrek B., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358 9 (2008) 900-909
43. McCarthy M.I., Abecasis G.R., Cardon L.R., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9 5 (2008) 356-369
44. Todd J.A., Walker N.M., Cooper J.D., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39 7 (2007) 857-864
45. Wellcome-Trust-Case-Control-Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 7145 (2007) 661-678
46. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 6 (2002) 554-558
47. Vitali C., Bombardieri S., Moutsopoulos H.M., et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36 3 (1993) 340-347
48. Locht H., Pelck R., and Manthorpe R. Clinical manifestations correlated to the prevalence of autoantibodies in a large (n = 321) cohort of patients with primary Sjogren's syndrome: a comparison of patients initially diagnosed according to the Copenhagen classification criteria with the American-European consensus criteria. Autoimmun Rev 4 5 (2005) 276-281
49. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature 401 6756 (1999) 921-923
50. Merriman T.R., and Todd J.A. Genetics of autoimmune disease. Curr Opin Immunol 7 6 (1995) 786-792
51. Nepom G.T. MHC and autoimmune diseases. Immunol Ser 59 (1993) 143-164
52. Chused T.M., Kassan S.S., Opelz G., et al. Sjogren's syndrome association with HLA-Dw3. N Engl J Med 296 16 (1977) 895-897
53. Fye K.H., Terasaki P.I., Michalski J.P., et al. Relationshipp of HLA-Dw3 and HLA-B8 to Sjogren's syndrome. Arthritis Rheum 21 3 (1978) 337-342
54. Manthorpe R., Morling N., Platz P., et al. HLA-D antigen frequencies in Sjogren's syndrome. Differences between the primary and secondary form. Scand J Rheumatol 10 2 (1981) 124-128
55. Anaya J.M., Mantilla R.D., and Correa P.A. Immunogenetics of primary Sjogren's syndrome in Colombians. Semin Arthritis Rheum 34 5 (2005) 735-743
56. Guggenbuhl P., Jean S., Jego P., et al. Primary Sjogren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes. J Rheumatol 25 5 (1998) 900-905
57. Mattey D.L., Gonzalez-Gay M.A., Hajeer A.H., et al. Association between HLA-DRB1*15 and secondary Sjogren's syndrome in patients with rheumatoid arthritis. J Rheumatol 27 11 (2000) 2611-2616
58. Nakken B., Jonsson R., Brokstad K.A., et al. Associations of MHC class II alleles in Norwegian primary Sjogren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen. Scand J Immunol 54 4 (2001) 428-433
59. Bolstad A.I., Wassmuth R., Haga H.J., et al. HLA markers and clinical characteristics in Caucasians with primary Sjogren's syndrome. J Rheumatol 28 7 (2001) 1554-1562
60. Kang H.I., Fei H.M., Saito I., et al. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjogren's syndrome. J Immunol 150 8 Pt 1 (1993) 3615-3623
61. Rischmueller M., Lester S., Chen Z., et al. HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS). Clin Exp Immunol 111 2 (1998) 365-371
62. Miyagawa S., Shinohara K., Nakajima M., et al. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects. Arthritis Rheum 41 5 (1998) 927-934
63. Scofield R.H., Frank M.B., Neas B.R., et al. Cooperative association of T cell beta receptor and HLA-DQ alleles in the production of anti-Ro in systemic lupus erythematosus. Clin Immunol Immunopathol 72 3 (1994) 335-341
64. Hadj Kacem H., Kaddour N., Adyel F.Z., et al. TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjogren's syndrome. Rheumatology (Oxford) 40 12 (2001) 1370-1374
65. Harley J.B., Reichlin M., Arnett F.C., et al. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjogren's syndrome. Science 232 4754 (1986) 1145-1147
66. Gershwin M.E., Terasaki I., Graw R., et al. Increased frequency of HL-A8 in Sjogren's syndrome. Tissue Antigens 6 5 (1975) 342-346
67. Ivanyi D., Drizhal I., Erbenova E., et al. HL-A in Sjogren's syndrome. Tissue Antigens 7 1 (1976) 45-51
68. Loiseau P., Lepage V., Djelal F., et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum Immunol 62 7 (2001) 725-731
69. Guggenbuhl P., Veillard E., Quelvenec E., et al. Analysis of TNFalpha microsatellites in 35 patients with primary Sjogren's syndrome. Joint Bone Spine 67 4 (2000) 290-295
70. Jean S., Quelvennec E., Alizadeh M., et al. DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjogren's syndrome genetic susceptibility. Clin Exp Rheumatol 16 6 (1998) 725-728
71. Kumagai S., Kanagawa S., Morinobu A., et al. Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjogren's syndrome. Arthritis Rheum 40 9 (1997) 1685-1692
72. Pertovaara M., Lehtimaki T., Rontu R., et al. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome. Rheumatology (Oxford) 43 12 (2004) 1484-1487
73. Petrek M., Cermakova Z., Hutyrova B., et al. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjogren's syndrome. Clin Exp Rheumatol 20 5 (2002) 701-703
74. Bolstad A.I., Wargelius A., Nakken B., et al. Fas and Fas ligand gene polymorphisms in primary Sjogren's syndrome. J Rheumatol 27 10 (2000) 2397-2405
75. Mullighan C.G., Heatley S., Lester S., et al. Fas gene promoter polymorphisms in primary Sjogren's syndrome. Ann Rheum Dis 63 1 (2004) 98-101
76. Morinobu A., Kanagawa S., Koshiba M., et al. Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjogren's syndrome in Japanese individuals. Arthritis Rheum 42 12 (1999) 2612-2615
77. Harangi M., Kaminski W.E., Fleck M., et al. Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjogren's syndrome. Eur J Immunol 35 1 (2005) 305-317
78. Perrier S., Coussediere C., Dubost J.J., et al. IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 87 3 (1998) 309-313
79. Youn J., Hwang S.H., Cho C.S., et al. Association of the interleukin-4 receptor alpha variant Q576R with Th1/Th2 imbalance in connective tissue disease. Immunogenetics 51 8-9 (2000) 743-746
80. Lester S., Downie-Doyle S., Gordon T.P., et al. The IL4-Ra Q57^R polymorphism is not associated with primary Sjorgren''s syndrome. Arthritis Rheum 43 Suppl (2000) s304
81. Ramos-Casals M., Font J., Brito-Zeron P., et al. Interleukin-4 receptor alpha polymorphisms in primary Sjogren's syndrome. Clin Exp Rheumatol 22 3 (2004) 374
82. Hulkkonen J., Pertovaara M., Antonen J., et al. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 40 6 (2001) 656-661
83. Limaye V., Lester S., Downie-Doyle S., et al. Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjogren's syndrome. J Rheumatol 27 12 (2000) 2945-2946
84. Origuchi T., Kawasaki E., Ide A., et al. Correlation between interleukin 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjogren's syndrome. Ann Rheum Dis 62 11 (2003) 1117-1118
85. Font J., Garcia-Carrasco M., Ramos-Casals M., et al. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome. Rheumatology (Oxford) 41 9 (2002) 1025-1030
86. Whittingham S., Propert D.N., and Mackay I.R. A strong association between the antinuclear antibody anti-La (SS-B) and the kappa chain allotype Km(1). Immunogenetics 19 4 (1984) 295-299
87. Downie-Doyle S., Lester S., Bardy P., et al. Immunoglobulin kappa light chain gene alleles are not associated with primary Sjogren's syndrome. Genes Immun 3 Suppl 1 (2002) S63-S65
88. Miceli-Richard C., Comets E., Loiseau P., et al. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum 56 12 (2007) 3989-3994
89. Wang Z.Y., Morinobu A., Kanagawa S., et al. Polymorphisms of the mannose binding lectin gene in patients with Sjogren's syndrome. Ann Rheum Dis 60 5 (2001) 483-486
90. Mullighan C.G., Heatley S., Bardy P.G., et al. Lack of association between mannose-binding lectin gene polymorphisms and primary Sjogren's syndrome. Arthritis Rheum 43 12 (2000) 2851-2852
91. Aittoniemi J., Pertovaara M., Hulkkonen J., et al. The significance of mannan-binding lectin gene alleles in patients with primary Sjogren's syndrome. Scand J Rheumatol 31 6 (2002) 362-365
92. Tsutsumi A., Sasaki K., Wakamiya N., et al. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Genes Immun 2 2 (2001) 99-104
93. Gomez L.M., Anaya J.M., Gonzalez C.I., et al. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases. Genes Immun 6 7 (2005) 628-631
94. Ittah M., Gottenberg J.E., Proust A., et al. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjogren's syndrome. Genes Immun 6 5 (2005) 457-458
95. Nakken B., Jonsson R., and Bolstad A.I. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjogren's syndrome. Arthritis Rheum 44 3 (2001) 638-646
96. Imanishi T., Morinobu A., Hayashi N., et al. A novel polymorphism of the SSA1 gene is associated with anti-SS-A/Ro52 autoantibody in Japanese patients with primary Sjogren's syndrome. Clin Exp Rheumatol 23 4 (2005) 521-524
97. Lawson C.A., Donaldson I.J., Bowman S.J., et al. Analysis of the insertion/deletion related polymorphism within T cell antigen receptor beta variable genes in primary Sjogren's syndrome. Ann Rheum Dis 64 3 (2005) 468-470
98. Gottenberg J.E., Busson M., Loiseau P., et al. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjogren's syndrome. Arthritis Rheum 50 2 (2004) 570-580
99. Hulkkonen J., Pertovaara M., Antonen J., et al. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. Arthritis Rheum 44 1 (2001) 176-179
100. Morinobu A., Gadina M., Strober W., et al. STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci U S A 99 19 (2002) 12281-12286
101. Nishikomori R., Usui T., Wu C.Y., et al. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol 169 8 (2002) 4388-4398
102. Remmers E.F., Plenge R.M., Lee A.T., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357 10 (2007) 977-986
103. Takaoka A., Yanai H., Kondo S., et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434 7030 (2005) 243-249
104. Taniguchi T., Ogasawara K., Takaoka A., et al. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19 (2001) 623-655
105. Graham R.R., Kyogoku C., Sigurdsson S., et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104 16 (2007) 6758-6763
106. Demirci F.Y., Manzi S., Ramsey-Goldman R., et al. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann Hum Genet 71 Pt 3 (2007) 308-311
107. Graham R.R., Kozyrev S.V., Baechler E.C., et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38 5 (2006) 550-555
108. Kelly J.A., Kelley J.M., Kaufman K.M., et al. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 9 3 (2008) 187-194
109. Kozyrev S.V., Lewen S., Reddy P.M., et al. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56 4 (2007) 1234-1241
110. Reddy M.V., Velazquez-Cruz R., Baca V., et al. Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet 121 6 (2007) 721-727
111. Shin H.D., Sung Y.K., Choi C.B., et al. Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res Ther 9 2 (2007) R32
112. Sigurdsson S., Nordmark G., Goring H.H., et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76 3 (2005) 528-537
113. Lee A.T., Li W., Liew A., et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 6 2 (2005) 129-133
114. Viken M.K., Amundsen S.S., Kvien T.K., et al. Association analysis of the 1858C > T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 6 3 (2005) 271-273
115. Hinks A., Barton A., John S., et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 52 6 (2005) 1694-1699
116. Kyogoku C., Langefeld C.D., Ortmann W.A., et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75 3 (2004) 504-507
117. Smyth D., Cooper J.D., Collins J.E., et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 11 (2004) 3020-3023
118. Vandiedonck C., Capdevielle C., Giraud M., et al. Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis. Ann Neurol 59 2 (2006) 404-407
119. Canton I., Akhtar S., Gavalas N.G., et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 6 7 (2005) 584-587
120. Jagiello P., Aries P., Arning L., et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 52 12 (2005) 4039-4043
121. Downie-Doyle S., Bayat N., Rischmueller M., et al. Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome. Arthritis Rheum 54 8 (2006) 2434-2440
122. Gottenberg J.E., Loiseau P., Azarian M., et al. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjogren syndrome. Arthritis Res Ther 9 2 (2007) R24
123. Graham D.S., Wong A.K., McHugh N.J., et al. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet 15 21 (2006) 3195-3205
124. Lester S., Downie-Doyle S., and Rischmueller M. CTLA4 polymorphism and primary Sjogren's syndrome. Arthritis Res Ther 9 3 (2007) 401 [author reply 402]
125. Ben-Chetrit E., Chan E.K., Sullivan K.F., et al. A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 167 5 (1988) 1560-1571
126. Pertovaara M., Hurme M., Antonen J., et al. Immunoglobulin KM and GM gene polymorphisms modify the clinical presentation of primary Sjogren's syndrome. J Rheumatol 31 11 (2004) 2175-2180
127. Hjelmervik T.O., Petersen K., Jonassen I., et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum 52 5 (2005) 1534-1544
128. Gottenberg J.E., Cagnard N., Lucchesi C., et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A 103 8 (2006) 2770-2775
129. Wakamatsu E., Matsumoto I., Yasukochi T., et al. Overexpression of phosphorylated STAT-1alpha in the labial salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 54 11 (2006) 3476-3484
130. Hu S., Wang J., Meijer J., et al. Salivary proteomic and genomic biomarkers for primary Sjogren's syndrome. Arthritis Rheum 56 11 (2007) 3588-3600
131. Soyfoo M.S., Steinfeld S., and Delporte C. Usefulness of mouse models to study the pathogenesis of Sjogren's syndrome. Oral Dis 13 4 (2007) 366-375
132. Kikutani H., and Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51 (1992) 285-322
133. Hu Y., Nakagawa Y., Purushotham K.R., et al. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am J Physiol 263 4 Pt 1 (1992) E607-E614
134. Cha S., Peck A.B., and Humphreys-Beher M.G. Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update. Crit Rev Oral Biol Med 13 1 (2002) 5-16
135. Fujita H., Fujihara T., Takeuchi T., et al. Lacrimation and salivation are not related to lymphocytic infiltration in lacrimal and salivary glands in MRL lpr/lpr mice. Adv Exp Med Biol 438 (1998) 941-948
136. Jonsson R., Tarkowski A., Backman K., et al. Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice. Clin Immunol Immunopathol 42 1 (1987) 93-101
137. Kessler H.S. A laboratory model for Sjogren's syndrome. Am J Pathol 52 3 (1968) 671-685
138. Hayashi T., Shirachi T., and Hasegawa K. Relationship between sialoadenitis and periductal laminin expression in the submandibular salivary gland of NZBxNZWF(1) mice. J Comp Pathol 125 2-3 (2001) 110-116
139. Saegusa J., and Kubota H. Sialadenitis in IQI/Jic mice: a new animal model of Sjögren's syndrome. J Vet Med Sci 59 10 (1997) 897-903
140. Takada K., Takiguchi M., Konno A., et al. Autoimmunity against a tissue kallikrein in IQI/Jic Mice: a model for Sjogren's syndrome. J Biol Chem 280 5 (2005) 3982-3988
141. Hayashi Y., Kojima A., Hata M., et al. A new mutation involving the sublingual gland in NFS/N mice. Partially arrested mucous cell differentiation. Am J Pathol 132 2 (1988) 187-191
142. Ishimaru N., Yoneda T., Saegusa K., et al. Severe destructive autoimmune lesions with aging in murine Sjogren's syndrome through Fas-mediated apoptosis. Am J Pathol 156 5 (2000) 1557-1564
143. Haneji N., Hamano H., Yanagi K., et al. A new animal model for primary Sjogren's syndrome in NFS/sld mutant mice. J Immunol 153 6 (1994) 2769-2777
144. Shinkura R., Kitada K., Matsuda F., et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat Genet 22 1 (1999) 74-77
145. Tsubata R., Tsubata T., Hiai H., et al. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjogren's syndrome. Eur J Immunol 26 11 (1996) 2742-2748
146. Li H., Dai M., and Zhuang Y. A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome. Immunity 21 4 (2004) 551-560
147. Hayakawa I., Tedder T.F., and Zhuang Y. B-lymphocyte depletion ameliorates Sjogren's syndrome in Id3 knockout mice. Immunology 122 1 (2007) 73-79
148. Fleck M., Kern E.R., Zhou T., et al. Murine cytomegalovirus induces a Sjogren's syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis Rheum 41 12 (1998) 2175-2184
149. Scofield R.H., Asfa S., Obeso D., et al. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome. J Immunol 175 12 (2005) 8409-8414